HRS Round-Up: Remote Pacemaker Monitoring Improves Survival
This article was originally published in The Gray Sheet
Executive Summary
Results of a St.Jude-sponsored trial of remote pacemaker monitoring was the highlight of the first two days of new clinical trial data presented at the Heart Rhythm Society annual scientific sessions in San Francisco.
You may also be interested in...
Will Watchman Prevail With FDA? Boston Scientific’s LAA Closure Trial Raises Questions, Controversy
The PREVAIL study of Boston Scientific’s Watchman left atrial appendage (LAA) closure device was primarily positive, but will it be enough to win FDA approval for the device?
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.